Back to Trades
Connaughton Bernadette
DirectorCIK 0001662521
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 13
- Companies
- 2
- Active
- 2025–2026
Connaughton Bernadette, Director, has filed 11 SEC reports (2025–2026), spread across 2 companies, totaling $1.8M in disclosed volume. Weighing $0 bought versus $1.3M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Aug 11 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $167.2K |
| Jul 2 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $124.7K |
| Jun 22 | EDIT Editas Medicine, Inc. | Connaughton Bernadette | Director | Award | $131.8K |
| Jun 2 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $107.6K |
| May 7 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Grant | $397.9K |
| May 5 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $103.2K |
| Jan 6 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $140.5K |
| Dec 1 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $59.4K |
| Nov 12 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $137.0K |
| Oct 1 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Insider | Sell | $150.5K |
| Sep 2 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Insider | Sell | $294.7K |
11 filings